NYSEAMERICAN:VNRX - VolitionRX Stock Price, Forecast & News

VolitionRX trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "VNRX."

VolitionRX Ltd (NYSEAMERICAN:VNRX) announced its quarterly earnings data on Tuesday, November, 12th. The medical research company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.01. The medical research company had revenue of $0.02 million for the quarter, compared to analysts' expectations of $0.06 million. View VolitionRX's Earnings History.

VolitionRX is scheduled to release their next quarterly earnings announcement on Wednesday, May 13th 2020. View Earnings Estimates for VolitionRX.

2 Wall Street analysts have issued 12 month price objectives for VolitionRX's stock. Their forecasts range from $5.00 to $8.00. On average, they expect VolitionRX's stock price to reach $6.50 in the next year. This suggests a possible upside of 89.0% from the stock's current price. View Analyst Price Targets for VolitionRX.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VolitionRX in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for VolitionRX.

News stories about VNRX stock have trended very negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VolitionRX earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave news headlines about the medical research company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future. View News Stories for VolitionRX.

Some companies that are related to VolitionRX include Spectral Medical (EDT), ANGLE (AGL), Proteome Sciences (PRM), DiaSorin (DIA), Polarityte (COOL) and Premaitha Health (NIPT).

Based on aggregate information from My MarketBeat watchlists, some companies that other VolitionRX investors own include Chesapeake Energy (CHK), Bausch Health Companies (BHC), Verastem (VSTM), Bausch Health Companies (BHC), Exelixis (EXEL), ContraFect (CFRX), Gilead Sciences (GILD), Verizon Communications (VZ), NovaBay Pharmaceuticals (NBY) and Crispr Therapeutics (CRSP).

VolitionRX's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Geode Capital Management LLC (0.50%), Renaissance Technologies LLC (0.13%), California Public Employees Retirement System (0.05%), Advisor Group Inc. (0.05%), Oxford Asset Management LLP (0.03%) and State Street Corp (0.03%). Company insiders that own VolitionRX stock include Cameron John Reynolds, Corp Ltd Eight, Guy Archibald Innes and Martin Charles Faulkes. View Institutional Ownership Trends for VolitionRX.

VNRX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Geode Capital Management LLC. View Insider Buying and Selling for VolitionRX.

VNRX stock was acquired by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Oxford Asset Management LLP, State Street Corp and Advisor Group Inc.. Company insiders that have bought VolitionRX stock in the last two years include Cameron John Reynolds, Corp Ltd Eight, Guy Archibald Innes and Martin Charles Faulkes. View Insider Buying and Selling for VolitionRX.

Shares of VNRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VNRX stock can currently be purchased for approximately $3.44.

VolitionRX has a market capitalization of $141.75 million. VolitionRX employs 44 workers across the globe.View Additional Information About VolitionRX.

The official website for VolitionRX is http://www.volitionrx.com/.

The medical research company can be reached via phone at 646 650 1351.